Pluri Inc. (PLUR)
NASDAQ: PLUR
· Real-Time Price · USD
4.40
0.10 (2.33%)
At close: Jun 13, 2025, 3:09 PM
4.80
9.09%
After-hours: Jun 13, 2025, 04:33 PM EDT
2.33% (1D)
| Bid | 4.25 |
| Market Cap | 34.46M |
| Revenue (ttm) | 1.03M |
| Net Income (ttm) | -20.9M |
| EPS (ttm) | -3.63 |
| PE Ratio (ttm) | -1.21 |
| Forward PE | -1.67 |
| Analyst | Buy |
| Ask | 4.95 |
| Volume | 2,180 |
| Avg. Volume (20D) | 19,093 |
| Open | 4.37 |
| Previous Close | 4.30 |
| Day's Range | 4.37 - 4.49 |
| 52-Week Range | 3.33 - 7.13 |
| Beta | 0.76 |
About PLUR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PLUR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PLUR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+4.76%
Pluri shares are trading higher after the company ...
Unlock content with
Pro Subscription
7 months ago
+11.84%
Brainstorm Cell Therapeutics and Pluri shares are trading higher after the companies entered into a memorandum of understanding to manufacture NurOwn for a Phase 3b trial in amyotrophic lateral sclerosis.
